ABSTRACT We have isolated a unique, basement membrane proteoglycan from the Engelbreth-Holm-Swarm (EHS) sarcoma. This proteoglycan, estimated to be 0.75 X 10w daltons, was found to contain about equal amounts of protein and covalently linked heparan sulfate. Antibody prepared against this proteoglycan reacts with the basement membrane matrix in the tumor and with the basement membranes in skin, kidney, and cornea. These studies indicate that the heparan sulfate proteoglycan is a normal constituent of basement membranes that presumably plays an important role in the organization of basement membrane components and that also may determine the permeability of basement membranes to acidic molecules.
Basement membranes are extracellular matrices that separate epithelial and endothelial cells from underlying connective tissues (1) . Basement membranes have been difficult to isolate and characterize, because they represent only a very small proportion of most tissues and their components are largely insoluble. However, it is known from chemical analyses of isolated basement membranes that they contain both collagenous (2) and noncollagenous proteins (3, 4) . Basement membrane collagen differs in size and amino acid composition from interstitial collagens and is found only in basement membrane. This protein is usually referred to as type IV collagen (5), although it may actually be two or more genetically distinct proteins (6) (7) (8) (9) .
Laminin, a large glycoprotein, has been isolated from the basement membrane produced by a murine tumor, the Engelbreth-Holm-Swarm (EHS) sarcoma (10) . Antibody against laminin reacts with basement membranes in a variety of tissues, including kidney, blood vessels, skin, and eye, indicating that laminin is another basement membrane-specific protein. In addition, fibronectin, another glycoprotein, is known to be associated with some basement membranes but it is not specific because it occurs in many other tissues and in blood (11) .
Biochemical studies have shown that extracellular matrices of a variety of connective tissues contain different types of glycosaminoglycans (12) (13) (14) . Glycosaminoglycans, in their native configuration, are covalently linked to protein to form proteoglycans. Histological studies have indicated that proteoglycans also may be components of basement membranes. Ruthenium red and cationized ferritin dyes, compounds that bind to anionic substances such as glycosaminoglycans, (15) (16) (17) bind to sites in basement membranes, as first described in developing tissues (18) . Because 35S04 iS incorporated into substances deposited in the basement membranes (19) , it has been suggested that these ionic sites in basement membranes are sulfated glycosaminoglycans. Studies have indicated that heparinase destroys the anionic sites in glomerular basement membranes (20) and that heparan sulfate is present in proteolytic digests of glomerular basement membranes (21) .
We have been studying the components of the basement membrane produced by a transplantable tumor, the EHS sarcoma. Tumor tissue can be obtained in quantity and, to our knowledge, the tissue lacks extracellular matrices other than basement membrane (22) . It contains type IV collagen(s) (6, 22) and laminin (10) . In this study we extracted proteoglycans from the tumor and partially characterized the largest of these macromolecules. Antibody prepared against this proteoglycan reacted with the basement membranes in all tissues examined. These observations indicate that basement membranes contain a unique proteoglycan, which we show contains heparan sulfate side chains.
MATERIALS AND METHODS
The EHS tumor was maintained by serial passage into the hind limb muscles of C57BL/6NJ mice (6, 22) . After 2-3 weeks, when the tumors had reached 1-2 cm in diameter, some of the animals were injected intraperitoneally with [6-3H] glucosamine-HCI (500 ,Ci per mouse) and sodium [a5S]sulfate (1-1.5 mCi per mouse) and sacrificed [18] [19] [20] hr later (1 Ci = 3.7 X 1010 becquerels). Tumors of similar size were collected from mice not receiving labeled compounds to obtain additional material for chemical analyses and immunization.
Weighed amounts of tumor tissues were extracted in 4 M guanidine-HCI containing 0.1 M 6-aminohexanoic acid, 0.01 M EDTA, 5 mM benzaminidine.Hl, and 0.5 M sodium acetate (pH 5.8) for 4 hr on a stirrer at 4°C (23) . The tissue was dispersed by passage of the suspension through the barrel of a 50-ml syringe. Subsequently, insoluble material was removed by centrifugation at 12,000 X g for 20 (27) . The proteoglycan-containing peaks separated by molecular sieve chromatography were dialyzed and lyophilized. Portions of the peaks were hydrolyzed in HC1 prior to analyses for sugar and amino acid composition. Hexosamines were separated on a Durrum amino acid analyzer after hydrolysis of samples in 4 M HCO at 105°C under vacuum for 8 hr. The amino acid composition of another portion was determined on the amino acid analyzer after hydrolysis in 6 M HC1 at 110°C under vacuum for 24 hr. Portions of the labeled peaks were also digested with papain (1 mg/ml) in 1.0 M sodium acetate (pH 6.5) at 60°C for 6 hr or were treated with 1 M sodium borohydride/0.05 M NaOH at 45°C for 24 hr. The digest was chromatographed on a Sepharose CL-6B column in 4 M guanidine-HCI/0.02 M Tris-HCI, pH 7.0, to isolate the glycosaminoglycan portion of the proteoglycan. The labeled peaks containing the glycosaminoglycans were chromatographed on a column of Sephadex G-50 (0.6 by 30 cm) with or without treatment with nitrous acid, crude heparinase (1 mg/ml) in 0.1 M Na acetate (pH 7.0) at 30°C for 16 hr, or chondroitinase ABC (28) .
Portions of the intact proteoglycan obtained from the molecular sieve column were also injected into rabbits to induce antibodies. In these studies, the proteoglycan (250 ,ug in 0.125 ml of saline) was mixed with an equal volume of Freund's complete adjuvant and injected into a superficial lymph node in the hind limb of a rabbit. Both 3 and 7 wk later, an additional injection of proteoglycan (240 ug/0. 125 ml) diluted with an equal volume of incomplete Freund's adjuvant was administered into the same area. Rabbits were bled every 2 wk, and the titer of antibody to the proteoglycan was measured by the en- (Fig. 1) . Most of the a5SO4-labeled material was eluted from the column as a single peak with a small trailing shoulder. Material in the fractions indicated by the bar in Fig. 1 was concentrated by filtration and applied to a Sepharose CL-4B column. The 35SO4-labeled material was partially resolved into two fractions (Fig. 2) ; the larger fraction, BM-1, contained a peak of protein coincident with the aS04 label. Colorimetric tests of these fractions showed that the uronic acid profile was similar to the distribution of a5SO4 (not shown). However, these fractions did not react with anthrone, indicating that they lacked hexose and therefore contained no keratan sulfate. protein, uronic acid, and sulfate suggested that the BM-1 peak contained a proteoglycan. By following these procedures, up to 1 mg (dry weight) of this proteoglycan was obtained from 10 g (wet weight) of tissue.
Electrophoresis of BM-1 material in 7.5% acrylamide gels containing sodium dodecyl sulfate followed by staining with Coomassie brilliant blue revealed a single component at the top of the gel with a molecular weight greater than 250,000 (not shown).
The sensitivity of BM-1 material to papain was studied to determine if protein was part of its structure. Untreated BM-1 material was excluded from a molecular sieve of Sepharose CL-6B (Fig. 3) . Papain digestion produced a labeled product (termed BM-la) that eluted later and was therefore smaller. Conversion of the 3H-and 5S-labeled material to a smaller molecular weight by papain demonstrates that it originally was linked to a protein core and existed as a proteoglycan. Incubation of the proteoglycan with dilute NaOH produced a similar reduction in the molecular weight of the 3H-and 35&Slabeled material. The molecular weight (31) , has an apparent molecular weight of about 70,000.
The chemical nature of the BM-la glycosaminoglycan was investigated by using various enzymes and chemical treatments known to degrade the various types of these materials. BM-la glycosaminoglycan, isolated by papain digestion and chromatography on Sepharose CL-6B, was incubated with and without chondroitinase ABC, heparinase, and nitrous acid. Degradation was assessed by the pattern of elution from Sephadex G-50 columns. Incubation with chondroitinase ABC did not alter its elution, indicating that BM-la glycosaminoglycan was not a chondroitin sulfate. Incubation with heparinase or nitrous acid degraded the glycosaminoglycan to a smaller molecular weight (Fig. 4) Antisera induced in rabbits by the injection of intact heparan sulfate proteoglycan were found to react strongly with the basement membrane proteoglycan and, to a lesser extent, with laminin when measured by the ELISA assay. Antibodies to laminin were removed by passage of the antisera over a column of laminin coupled to Sepharose. Subsequently, the effluent from this column was passed through a column of Sepharose with the proteoglycan fraction (BM-1) from the molecular sieve covalently attached. The antibody that bound to this column was eluted and concentrated. This antibody showed a strong reaction with the heparan sulfate proteoglycan but not with laminin, type IV collagen, or the proteoglycans from cartilage or the corneal stroma. Incubating the heparan sulfate proteoglycan with dilute base abolished this reaction, whereas digestion with heparinase increased the reaction 10-fold. These results indicate that the antibodies are directed against the protein core of the heparan sulfate proteoglycan. These antibodies were used to study the distribution of the heparan sulfate proteoglycan in the EHS sarcoma and in various normal tissues by the indirect immunofluorescence procedure (Fig. 5) . The matrix of the tumor showed a strong reaction with the antibody, particularly in the matrix closest to the cells. The antibody reacted strongly with basement membranes in sections of human skin, including those between the epidermis and dermis and around blood vessels and hair follicles. The basement membranes in the kidney glomeruli and tubules were positively stained, as were Bowman's and Descemet's membranes in the cornea. DISCUSSION We report here the isolation and partial characterization of a proteoglycan that is one of the unique constituents of basement membranes. This proteoglycan was prepared from a mouse tumor from which other constituents of basement membrane were previously isolated, including type IV collagen(s) and laminin. The largest of the sulfated macromolecules extracted from the tumor was shown to be a proteoglycan, based on the density in which it sedimented in CsCl, its chromatographic properties on DEAE-cellulose, its chemical composition, and its susceptibility to enzymatic and chemical degradation. The glycosaminoglycan chains are covalently linked to the protein core and were identified as heparan sulfate, based on their susceptibility to degradation by crude heparinase and nitrous acid but not by chondroitinase ABC.
An estimate of the size of the proteoglycan was obtained by comparing its elution from a molecular sieve column with the elution of proteoglycans from cartilage and from cornea (32) , the size and composition of which are better known. The cartilage proteoglycan, Mr 1.5-2 X 106, is excluded from Sepharose CL-4B and emerges in the void volume of the column. This proteoglycan is almost 90% carbohydrate and only 10% protein. in the tumor matrix. In most sections examined, the antibody showed a somewhat greater reaction in those areas of the matrix closest to the cells. This pattern resembles that observed with antibody to laminin, whereas antibody to type IV collagen is more evenly distributed throughout the tumor matrix. Laminin has been loclized to the lamina lucida of the epidermal-dermal basement membrane (34) whereas type IV collagen is located in the lamina densa (35) . The basement membrane proteoglycan may be localized in the lamina lucida zone along with laminin.
Strong reactions with the purified antibodies were observed with the basement membranes in sections of skin and kidney cortex of mouse and human In the cornea, both Descemet's and Bowman's membranes also showed strong reactions. However, it should be noted that, although Bowman's membrane contains a basement membrane, fibrillar components constitute the majority of this structure. This indicates that the heparan sulfate proteoglycan, or an antigenically related molecule, is a constituent of this extracellular matrix common to all of these tissues. These data offer an explanation for the previous observations that have shown a5S04 to be incorporated into basement membranes. In addition the anionic sites previously found to be constituents of basement membranes are most likely contributed by the basement membrane proteoglycan described here. This specific component could have a structural role in the basement membrane and may regulate the passage of negatively charged molecules across the basement membrane. In certain pathological states, such as aminonucleoside nephrosis, a loss of anionic sites has been described (36) . The increase in permeability of the basement membrane in this condition could arise from a loss of the basement membrane proteoglycan.
